VolitionRx Limited (VNRX)
VolitionRx Statistics
Share Statistics
VolitionRx has 95.97M shares outstanding. The number of shares has increased by 16.94% in one year.
| Shares Outstanding | 95.97M |
| Shares Change (YoY) | 16.94% |
| Shares Change (QoQ) | 4.2% |
| Owned by Institutions (%) | 21.27% |
| Shares Floating | 71.58M |
| Failed to Deliver (FTD) Shares | 3.63K |
| FTD / Avg. Volume | 3.33% |
Short Selling Information
The latest short interest is 441.92K, so 0.46% of the outstanding shares have been sold short.
| Short Interest | 441.92K |
| Short % of Shares Out | 0.46% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 3.71 |
Valuation Ratios
The PE ratio is -1.45 and the forward PE ratio is -3.42. VolitionRx's PEG ratio is 0.16.
| PE Ratio | -1.45 |
| Forward PE | -3.42 |
| PS Ratio | 65.88 |
| Forward PS | 0.2 |
| PB Ratio | -6.55 |
| P/FCF Ratio | -2.67 |
| PEG Ratio | 0.16 |
Enterprise Valuation
VolitionRx Limited has an Enterprise Value (EV) of 36.2M.
| EV / Earnings | -1.03 |
| EV / Sales | 46.7 |
| EV / EBITDA | -1.06 |
| EV / EBIT | -1.01 |
| EV / FCF | -1.89 |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of -0.75.
| Current Ratio | 0.69 |
| Quick Ratio | 0.69 |
| Debt / Equity | -0.75 |
| Total Debt / Capitalization | -301.26 |
| Cash Flow / Debt | -3.08 |
| Interest Coverage | -162.38 |
Financial Efficiency
Return on equity (ROE) is 4.53% and return on capital (ROIC) is 1260.79%.
| Return on Equity (ROE) | 4.53% |
| Return on Assets (ROA) | -1.26% |
| Return on Capital (ROIC) | 1260.79% |
| Revenue Per Employee | $8,076.06 |
| Profits Per Employee | $-367,907.06 |
| Employee Count | 96 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -31.31% in the last 52 weeks. The beta is 1.1, so VolitionRx's price volatility has been higher than the market average.
| Beta | 1.1 |
| 52-Week Price Change | -31.31% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (20 Days) | 109.16K |
Income Statement
In the last 12 months, VolitionRx had revenue of 775.3K and earned -35.32M in profits. Earnings per share was -0.5.
| Revenue | 775.3K |
| Gross Profit | 775.3K |
| Operating Income | -35.99M |
| Net Income | -35.32M |
| EBITDA | -34.04M |
| EBIT | -35.99M |
| Earnings Per Share (EPS) | -0.5 |
Balance Sheet
The company has 20.73M in cash and 5.86M in debt, giving a net cash position of 14.87M.
| Cash & Cash Equivalents | 20.73M |
| Total Debt | 5.86M |
| Net Cash | 14.87M |
| Retained Earnings | -202.58M |
| Total Assets | 12.68M |
| Working Capital | -23.48M |
Cash Flow
In the last 12 months, operating cash flow was -18.06M and capital expenditures -1.08M, giving a free cash flow of -19.15M.
| Operating Cash Flow | -18.06M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -19.15M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 100%, with operating and profit margins of -4.64K% and -4.56K%.
| Gross Margin | 100% |
| Operating Margin | -4.64K% |
| Pretax Margin | -4.6K% |
| Profit Margin | -4.56K% |
| EBITDA Margin | -4.39K% |
| EBIT Margin | -4.64K% |
| FCF Margin | -2.47K% |
Dividends & Yields
VNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -96.15% |
| FCF Yield | -38.4% |
Analyst Forecast
The average price target for VNRX is $5, which is 861.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $5 |
| Price Target Difference | 861.5% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -33.71 |
| Piotroski F-Score | 3 |